Workflow
Aclaris Therapeutics(ACRS) - 2025 Q4 - Annual Report
2026-02-26 21:31
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 Commission file number 001-37581 ACLARIS THERAPEUTICS, INC. Incorporated under the Laws of the I.R.S. Employer Identification No. State of Delaware 46-0571712 701 Lee Road, Suite 103 Wayne, PA 19087 (484) 324-7933 Securities registered pursuant to Section 12(b) of the Act: Title of ...
SITE Centers (SITC) - 2025 Q4 - Annual Report
2026-02-26 21:31
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-11690 SITE Centers Corp. (Exact Name of Registrant as Specified in Its Charter) Ohio 34-1723097 (State or Other Jurisdiction of Incorpo ...
Lightbridge(LTBR) - 2025 Q4 - Annual Report
2026-02-26 21:31
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-34487 LIGHTBRIDGE CORPORATION Nevada 91-1975651 ...
Adaptive Biotechnologies(ADPT) - 2025 Q4 - Annual Report
2026-02-26 21:31
OR UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____to _____ Commission File Number: 001-38957 ADAPTIVE BIOTECHNOLOGIES CORPORATION (Exact Name of Registrant as Specified in its Charter) Washington 27-0907024 (St ...
SoundHound AI(SOUN) - 2025 Q4 - Annual Results
2026-02-26 21:30
SOUNDHOUND AI, INC. CONSOLIDATED BALANCE SHEETS (In thousands, except share and per share data) | | | December 31, | | December 31, | | | --- | --- | --- | --- | --- | --- | | | | 2025 | | 2024 | | | | | (Unaudited) | | | | | ASSETS Current assets: | | | | | | | Cash and cash equivalents | $ | 248,490 | $ | | 198,240 | | Accounts receivable, net of allowances of $2,254 and $726 as of December 31, 2025 and 2024, respectively | | 32,336 | | | 23,159 | | Contract assets and unbilled revenue, net | | 38,189 | | ...
Alta Equipment (ALTG) - 2025 Q4 - Annual Results
2026-02-26 21:30
Livonia, MI. – February 26, 2026 – Alta Equipment Group Inc. (NYSE: ALTG) ("Alta", "we", "our" or the "Company"), a leading provider of premium material handling, construction, and environmental processing equipment and related services, today announced financial results for the fourth quarter and full year ended December 31, 2025. CEO Comment: Ryan Greenawalt, Chief Executive Officer of Alta, said "Our fourth quarter equipment sales performance was encouraging as demand for equipment significantly improved ...
Palmer Square Capital BDC(PSBD) - 2025 Q4 - Annual Results
2026-02-26 21:30
Exhibit 99.1 Palmer Square Capital BDC Inc. Announces Fourth Quarter and Full Year 2025 Financial Results Declares First Quarter 2026 Base Dividend of $0.36 Per Share with Supplemental Dividend Expected to be Announced in March MISSION WOODS, Kansas, February 26, 2026 — Palmer Square Capital BDC Inc. (NYSE: PSBD) ("PSBD" or the "Company"), an externally managed business development company, today announced its financial results for the fourth quarter and full year ended December 31, 2025. Financial and Oper ...
Apollo Investment(AINV) - 2026 Q3 - Quarterly Results
2026-02-26 21:30
Exhibit 99.1 MidCap Financial Investment Corporation Reports Financial Results for the Quarter and Fiscal Year Ended December 31, 2025 Board Authorized New $100 Million Stock Repurchase Plan Results for the Quarter and Fiscal Year Ended December 31, 2025, and Other Recent Highlights: New York, NY — February 26, 2026 — MidCap Financial Investment Corporation (NASDAQ: MFIC) or the "Company," today announced financial results for the quarter and fiscal year ended December 31, 2025. The Company's net investment ...
Mativ(MATV) - 2025 Q4 - Annual Report
2026-02-26 21:30
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from __________________ to __________________ 1-13948 (Commission file number) MATIV HOLDINGS, INC. (Exact name of registrant as specified in its charter) (State or oth ...
MidCap Financial Investment (MFIC) - 2026 Q3 - Quarterly Results
2026-02-26 21:30
MidCap Financial Investment Corporation Reports Financial Results for the Quarter and Fiscal Year Ended December 31, 2025 Board Authorized New $100 Million Stock Repurchase Plan Results for the Quarter and Fiscal Year Ended December 31, 2025, and Other Recent Highlights: Exhibit 99.1 New York, NY — February 26, 2026 — MidCap Financial Investment Corporation (NASDAQ: MFIC) or the "Company," today announced financial results for the quarter and fiscal year ended December 31, 2025. The Company's net investment ...